期刊文献+

HIF-2、Twist在胰腺癌组织中的表达及其临床意义

Expressions and significance of HIF-2 and Twist in pancreatic cancer
原文传递
导出
摘要 目的探讨缺氧诱导因子2(HIF-2)和Twist在胰腺癌组织中的表达及其临床意义。方法采用免疫组化SP法检测56例胰腺癌及其癌旁组织中HIF-2和Twist的表达,分析其与临床病理指标的关系。结果 HIF-2阳性染色主要定位于细胞质,HIF-2在胰腺癌组织中阳性表达率高于癌旁组织(76.8%vs.28.6%)(P<0.01)。Twist阳性染色定位于细胞质或细胞核,Twist在胰腺癌组织阳性表达率高于癌旁组织(69.6%vs.21.4%)(P<0.01)。HIF-2阳性表达与肿瘤大小、临床分期、淋巴结转移及血管侵犯密切相关(P<0.01或P<0.05)。Twist阳性表达与淋巴结转移及血管侵犯密切相关(P<0.01)。HIF-2与Twist在胰腺癌组织中的表达呈正相关(r=0.65,P<0.01)。结论 HIF-2和Twist在胰腺癌组织中高表达;HIF-2和Twist的表达与肿瘤侵袭和转移密切相关,可能成为潜在的抗肿瘤治疗靶点。 Objective To explore the expressions and significance of hypoxia inducing factor(HIF)-2 and Twist in pancreatic cancer.Methods The expressions of HIF-2 and Twist in 56 pairs of pancreatic cancer tissues and tumor-adjacent mucosa were detected by immunohistochemistry SP method.The relationship between the expressions and clinicopathologic indicators was analyzed.Results HIF-2 positive staining mainly located in cytoplasm.The positive expression rate of HIF-2 was higher in pancreatic cancer than that in tumor-adjacent mucosa(76.8% vs.28.6%)(P〈0.01).Twist positive staining located in cytoplasm or nucleus.The positive expression rate of Twist was higher in pancreatic cancer than that in tumor-adjacent mucosa(69.6% vs.21.4%)(P〈0.01).The expression of HIF-2 was closely related to tumor size,clinical staging,lymph node metastasis and vascular invasion(P〈0.01 or P〈0.05).The expression of Twist was closely related to tumor invasion and metastasis(P〈0.01).HIF-2 expression was positively correlated to Twist expression in pancreatic cancer tissues(r=0.65,P〈0.01).Conclusion HIF-2 and Twist are highly expressed in pancreatic cancer,which are closely associated with tumor invasion and metastasis and could be the potential targets for antitumor therapy.
出处 《江苏医药》 CAS 2016年第6期633-635,F0002,共4页 Jiangsu Medical Journal
基金 国家自然科学基金(81302146) 江苏省高校自然科学基金(13KJB320018)
关键词 胰腺癌 缺氧诱导因子 TWIST Pancreatic cancer Hypoxia inducing factor Twist
  • 相关文献

参考文献11

  • 1范凤凤,杨华锋,唐鲁兵,李占文.缺氧诱导因子1α和Ki67在三阴性乳腺癌中的表达及意义[J].江苏医药,2015,41(3):268-270. 被引量:6
  • 2Rankin EB,Giaccia AJ.The role of hypoxia-inducible factors in tumorigenesis[J].Cell Death Differ,2008,15(4):678-685.
  • 3顾纪明,吴露露,陈进,周士福,金琳芳.结直肠癌组织中Twist、MMP-2和MMP-9的表达及意义[J].江苏医药,2010,36(16):1895-1896. 被引量:8
  • 4张尤历,姚志新,徐岷,周志华,吴岩,朱立宁.食管鳞癌组织中组蛋白去乙酰化酶2的表达及临床意义[J].江苏医药,2012,38(17):2037-2039. 被引量:3
  • 5Harris AL.Hypoxia-a key regulatory factor in tumour growth[J].Nat Rev Cancer,2002,2(1):38-47.
  • 6Lu X,Kang Y.Hypoxia and hypoxia-inducible factors:master regulators of metastasis[J].Clin Cancer Res,2010,16(24):5928-5935.
  • 7Keith B,Johnson RS,Simon MC.HIF1αand HIF2α:sibling rivalry in hypoxic tumour growth and progression[J].Nat Rev Cancer,2011,12(1):9-22.
  • 8Yoshimura H,Dhar DK,Kohno H,et al.Prognostic impact of hypoxia-inducible factors 1alpha and 2alpha in colorectal cancer patients:correlation with tumor angiogenesis and cyclooxygenase-2expression[J].Clin Cancer Res,2004,10(24):8554-8560.
  • 9Kwok WK,Ling MT,Lee TW,et al.Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target[J].Cancer Res,2005,65(12):5153-5162.
  • 10Niu RF,Zhang L,Xi GM,et al.Up-regulation of Twist induces angiogenesis and correlates with metastasis in hepatocellular carcinoma[J].J Exp Clin Cancer Res,2007,26(3):385-394.

二级参考文献22

  • 1黄菊,程夏楷,杨彬,吴兴中.E-钙黏蛋白复合体及其对肿瘤细胞的作用[J].生命的化学,2005,25(3):247-250. 被引量:19
  • 2杨锦建,张秋红,贾占奎,周四维.基质金属蛋白酶(MMP)9、MMP2 mRNA及基质金属蛋白酶抑制剂2 mRNA在人膀胱移行细胞癌中的表达及意义[J].中华实验外科杂志,2006,23(4):594-595. 被引量:33
  • 3Kang Y, Massague J. Epithelial-mesenchymal transitions:twist in development and metastasis [J ]. Cell, 2004, 118 ( 3 ) : 277- 279.
  • 4Mat suyama Y, Takao S, Aikou T. Comparison of matrix metalloproteinase expression between primary tumors with or without liver metastasis in pancreatic and colorectal carcinomas[J]. J Surg Oncol,2002,80(2) : 105-110.
  • 5Gregoretti IV, Lee YM, Goodson HV. Molecular evolution of the historte deacetylase family: functional implications of phylogenetic analysis[J]. J Mol Biol,2004,338(1):17-31.
  • 6Edge SB, Byrd DR, Compton CC, et al. AJCC Cancer Staging Manual[M]. 7^th ed. New York: Springer, 2009: 1.
  • 7Mutze K, Langer R, Becker K, et al. Histone deacetylase (HDAC) 1 and 2 expression and chemotherapy in gastric cancer[J]. Ann Surg Oncol, 2010,17(12) : 3336-3343.
  • 8Marshall GM, Gherardi S, Xu N, et al. Transcriptional upregulation of histone deacetylase 2 promotes Myc-induced oncogenic effects[J]. Oncogene, 2010,29(44):5957-5968.
  • 9Kramer OH. HDAC2.. a critical factor in health and disease [J]. Trends Pharmacol Sci, 2009,30(12) : 647-655.
  • 10Langer R, ;Mutze K, Pecker K, et al. Expression of class Ⅰ histone deaeetylases (HDAC1 and HDAC2 ) in oesophageal adenoeareinomas: an immunohistoehemical study [J]. J Clin Pathol, 2010,63(11) : 994-998.

共引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部